Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 152.65 USD 3.84% Market Closed
Market Cap: 7.7B USD

Wall Street
Price Targets

AXSM Price Targets Summary
Axsome Therapeutics Inc

Wall Street analysts forecast AXSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXSM is 182.31 USD with a low forecast of 149.48 USD and a high forecast of 215.25 USD.

Lowest
Price Target
149.48 USD
2% Downside
Average
Price Target
182.31 USD
19% Upside
Highest
Price Target
215.25 USD
41% Upside
Axsome Therapeutics Inc Competitors:
Price Targets
VY4
SNDL Inc
181% Upside
SPL
Starpharma Holdings Ltd
75% Upside
AQST
Aquestive Therapeutics Inc
81% Upside
000423
Dong-E-E-Jiao Co Ltd
60% Upside
2096
Simcere Pharmaceutical Group Ltd
26% Upside
WEED
Canopy Growth Corp
85% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
34% Upside
002001
Zhejiang Nhu Co Ltd
26% Upside

Revenue
Forecast

Revenue Estimate
Axsome Therapeutics Inc

The compound annual growth rate of Axsome Therapeutics Inc's revenue for the next 4 years is 52%.

N/A
Past Growth
52%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Axsome Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Axsome Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AXSM's stock price target?
Price Target
182.31 USD

According to Wall Street analysts, the average 1-year price target for AXSM is 182.31 USD with a low forecast of 149.48 USD and a high forecast of 215.25 USD.

What is Axsome Therapeutics Inc's Revenue forecast?
Projected CAGR
52%

The compound annual growth rate of Axsome Therapeutics Inc's revenue for the next 4 years is 52%.

Back to Top